• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
The histopathology of myeloma in the bone marrow.骨髓中骨髓瘤的组织病理学。
J Clin Exp Hematop. 2018;58(2):61-67. doi: 10.3960/jslrt.18014.
2
Histopathology in the diagnosis and classification of acute myeloid leukemia, myelodysplastic syndromes, and myelodysplastic/myeloproliferative diseases.组织病理学在急性髓系白血病、骨髓增生异常综合征及骨髓增生异常/骨髓增殖性疾病的诊断与分类中的应用
Pathobiology. 2007;74(2):97-114. doi: 10.1159/000101709.
3
Histopathology in the diagnosis of high-risk myelodysplastic syndromes.组织病理学在高危骨髓增生异常综合征诊断中的应用
J Clin Exp Hematop. 2018;58(2):51-60. doi: 10.3960/jslrt.18009.
4
Histomorphology of multiple myeloma on bone marrow biopsy.骨髓活检中多发性骨髓瘤的组织形态学
Indian J Pathol Microbiol. 2004 Jul;47(3):359-63.
5
Plasma cell morphology in multiple myeloma and related disorders.多发性骨髓瘤及相关疾病中的浆细胞形态学。
Morphologie. 2015 Jun;99(325):38-62. doi: 10.1016/j.morpho.2015.02.001. Epub 2015 Apr 18.
6
Immunohistochemical detection of p53, mdm2, waf1/p21, and Ki67 proteins in bone marrow biopsies in myelodysplastic syndroms, acute myelogenous leukaemias and chronic myeloproliferative disorders.骨髓活检中p53、mdm2、waf1/p21和Ki67蛋白在骨髓增生异常综合征、急性髓系白血病和慢性骨髓增殖性疾病中的免疫组织化学检测
Clin Exp Pathol. 1999;47(5):231-8.
7
Myelodysplastic syndromes: preleukemic or early leukemic conditions?骨髓增生异常综合征:白血病前期还是早期白血病状态?
Haematol Blood Transfus. 1990;33:3-7. doi: 10.1007/978-3-642-74643-7_1.
8
[Cytogenetic abnormalities and morphological changes of bone marrow in multiple myeloma: a pathological analysis of 151 cases].[多发性骨髓瘤的细胞遗传学异常及骨髓形态学改变:151例病例的病理分析]
Zhonghua Bing Li Xue Za Zhi. 2020 Nov 8;49(11):1136-1141. doi: 10.3760/cma.j.cn112151-20200306-00178.
9
Diagnostic yield of bone marrow and peripheral blood FISH panel testing in clinically suspected myelodysplastic syndromes and/or acute myeloid leukemia: a prospective analysis of 433 cases.临床疑诊骨髓增生异常综合征和/或急性髓系白血病患者行骨髓和外周血 FISH -panel 检测的诊断效能:433 例前瞻性分析。
Am J Clin Pathol. 2011 Jun;135(6):915-20. doi: 10.1309/AJCPW10YBRMWSWYE.
10
Diagnostic criteria to distinguish hypocellular acute myeloid leukemia from hypocellular myelodysplastic syndromes and aplastic anemia: recommendations for a standardized approach.区分低细胞性急性髓系白血病与低细胞性骨髓增生异常综合征及再生障碍性贫血的诊断标准:标准化方法的建议
Haematologica. 2009 Feb;94(2):264-8. doi: 10.3324/haematol.13755. Epub 2009 Jan 14.

引用本文的文献

1
Plasma Cell Leukemia With Spindle-Cell Morphology and CD22 Positivity on Flow Cytometry.具有梭形细胞形态且流式细胞术检测CD22阳性的浆细胞白血病
Cureus. 2025 May 3;17(5):e83402. doi: 10.7759/cureus.83402. eCollection 2025 May.
2
Neuroscience of cancer: Research progress and emerging of the field.癌症神经科学:该领域的研究进展与新进展
Ibrain. 2024 Aug 14;10(3):305-322. doi: 10.1002/ibra.12172. eCollection 2024 Fall.
3
Bone marrow fibrosis in newly diagnosed multiple myeloma and its correlation with clinicopathological factors.初诊多发性骨髓瘤患者骨髓纤维化及其与临床病理因素的相关性。
Diagn Pathol. 2024 Jul 18;19(1):99. doi: 10.1186/s13000-024-01516-y.
4
Optimized Liposomal Delivery of Bortezomib for Advancing Treatment of Multiple Myeloma.硼替佐米的优化脂质体递送用于推进多发性骨髓瘤的治疗
Pharmaceutics. 2023 Nov 25;15(12):2674. doi: 10.3390/pharmaceutics15122674.
5
Malignant Brain and Spinal Tumors Originating from Bone or Cartilage.来源于骨或软骨的恶性脑和脊髓肿瘤。
Adv Exp Med Biol. 2023;1405:477-506. doi: 10.1007/978-3-031-23705-8_18.
6
Drug combinations identified by high-throughput screening promote cell cycle transition and upregulate Smad pathways in myeloma.高通量筛选鉴定的药物组合促进骨髓瘤细胞周期转换并上调 Smad 通路。
Cancer Lett. 2023 Aug 1;568:216284. doi: 10.1016/j.canlet.2023.216284. Epub 2023 Jun 24.
7
Enrichment-Free Single-Cell Detection and Morphogenomic Profiling of Myeloma Patient Samples to Delineate Circulating Rare Plasma Cell Clones.无富集的骨髓瘤患者样本单细胞检测与类器官基因分析以描绘循环稀有浆细胞克隆。
Curr Oncol. 2022 Apr 21;29(5):2954-2972. doi: 10.3390/curroncol29050242.
8
Plasma cell myeloma: role of histopathology, immunophenotyping, and genetic testing.浆细胞骨髓瘤:组织病理学、免疫表型和基因检测的作用。
Skeletal Radiol. 2022 Jan;51(1):17-30. doi: 10.1007/s00256-021-03754-3. Epub 2021 Mar 9.
9
Rapidly Progressive Acute Liver Failure in Relapsed Multiple Myeloma.复发多发性骨髓瘤中的快速进展性急性肝衰竭
Cureus. 2020 Dec 28;12(12):e12346. doi: 10.7759/cureus.12346.
10
Plasma Cell Myeloma with an Aggressive Clinical Course and Anaplastic Morphology in a 22-Year-Old Patient: A Case Report and Review of Literature.一名22岁患者的具有侵袭性临床病程和间变性形态的浆细胞骨髓瘤:病例报告及文献复习
Am J Case Rep. 2020 Mar 10;21:e920489. doi: 10.12659/AJCR.920489.

本文引用的文献

1
International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma.国际骨髓瘤工作组更新了多发性骨髓瘤的诊断标准。
Lancet Oncol. 2014 Nov;15(12):e538-48. doi: 10.1016/S1470-2045(14)70442-5. Epub 2014 Oct 26.
2
Widespread genetic heterogeneity in multiple myeloma: implications for targeted therapy.多发性骨髓瘤的广泛遗传异质性:对靶向治疗的影响。
Cancer Cell. 2014 Jan 13;25(1):91-101. doi: 10.1016/j.ccr.2013.12.015.
3
Myeloma cell morphology and morphometry in correlation with clinical stages and survival.骨髓瘤细胞形态学及形态测量学与临床分期和生存的相关性
Diagn Cytopathol. 2013 Nov;41(11):947-54. doi: 10.1002/dc.22986. Epub 2013 Apr 3.
4
Molecular pathogenesis of multiple myeloma: basic and clinical updates.多发性骨髓瘤的分子发病机制:基础与临床更新。
Int J Hematol. 2013 Mar;97(3):313-23. doi: 10.1007/s12185-013-1291-2. Epub 2013 Feb 28.
5
Plasma cell leukemia: consensus statement on diagnostic requirements, response criteria and treatment recommendations by the International Myeloma Working Group.浆细胞白血病:国际骨髓瘤工作组关于诊断要求、反应标准和治疗建议的共识声明。
Leukemia. 2013 Apr;27(4):780-91. doi: 10.1038/leu.2012.336. Epub 2012 Nov 21.
6
Molecular pathogenesis of multiple myeloma and its premalignant precursor.多发性骨髓瘤及其恶性前体的分子发病机制。
J Clin Invest. 2012 Oct;122(10):3456-63. doi: 10.1172/JCI61188. Epub 2012 Oct 1.
7
Patterns of expression of CD56 and CD117 on neoplastic plasma cells and association with genetically distinct subtypes of plasma cell myeloma.肿瘤性浆细胞上 CD56 和 CD117 的表达模式与浆细胞骨髓瘤的遗传上不同亚型的关联。
Leuk Lymphoma. 2012 Oct;53(10):1905-10. doi: 10.3109/10428194.2012.676174. Epub 2012 Apr 19.
8
Pathogenesis of monoclonal gammopathy of undetermined significance and progression to multiple myeloma.意义未明的单克隆丙种球蛋白血症的发病机制及进展为多发性骨髓瘤。
Semin Hematol. 2011 Jan;48(1):4-12. doi: 10.1053/j.seminhematol.2010.11.003.
9
Immunophenotyping in multiple myeloma and related plasma cell disorders.多发性骨髓瘤及相关浆细胞疾病的免疫表型分析。
Best Pract Res Clin Haematol. 2010 Sep;23(3):433-51. doi: 10.1016/j.beha.2010.09.002.
10
International Myeloma Working Group molecular classification of multiple myeloma: spotlight review.国际骨髓瘤工作组多发性骨髓瘤分子分类:重点综述。
Leukemia. 2009 Dec;23(12):2210-21. doi: 10.1038/leu.2009.174. Epub 2009 Oct 1.

骨髓中骨髓瘤的组织病理学。

The histopathology of myeloma in the bone marrow.

作者信息

Fujino Masahiko

出版信息

J Clin Exp Hematop. 2018;58(2):61-67. doi: 10.3960/jslrt.18014.

DOI:10.3960/jslrt.18014
PMID:29998977
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6413148/
Abstract

Myeloma is characterized by the neoplastic proliferation of monoclonal plasma cells. A diagnosis of myeloma is based on the criteria proposed by the International Myeloma Working Group and the pathological findings.Myeloma cells are classified into four types: mature, immature, pleomorphic, and plasmablastic. There are three patterns in which myeloma infiltrates bone marrow - nodular, interstitial, and diffuse. Dutcher bodies are highly specific to neoplastic myeloma cells. On immunohistochemical staining, the specificity of CD138 is high for plasma cells. As a clear image is often not obtained from the immunohistochemical staining of the immunoglobulin light chain, in situ hybridization is recommended. Abnormal expression of CD56 is seen in 70-80% of cases by flow cytometry analysis. CD56 expression definitively indicates myeloma, suggesting its high diagnostic value. Evaluation of the infiltration pattern, monoclonality, and abnormal antigen expression of plasma cells is more important than the plasmocytic ratio to determine whether a case is reactive or neoplastic.Multiple gene abnormalities function in the onset and progression of myeloma. In our department, we analyze CCND1, FGFR3, MAF, and del (17p13) by FISH for all myeloma cases. None of the cases with genetic abnormalities were recognized by G-banding. Therefore, FISH is more effective than G-banding for the evaluation of genetic abnormalities in myeloma.

摘要

骨髓瘤的特征是单克隆浆细胞的肿瘤性增殖。骨髓瘤的诊断基于国际骨髓瘤工作组提出的标准和病理检查结果。骨髓瘤细胞分为四种类型:成熟型、未成熟型、多形性和浆母细胞型。骨髓瘤浸润骨髓有三种模式——结节状、间质型和弥漫型。杜氏小体对肿瘤性骨髓瘤细胞具有高度特异性。在免疫组化染色中,CD138对浆细胞的特异性较高。由于免疫球蛋白轻链的免疫组化染色通常难以获得清晰图像,因此建议采用原位杂交。通过流式细胞术分析,70 - 80%的病例可见CD56异常表达。CD56表达明确提示骨髓瘤,表明其具有较高的诊断价值。评估浆细胞的浸润模式、单克隆性和异常抗原表达对于判断病例是反应性还是肿瘤性比浆细胞比例更为重要。多种基因异常在骨髓瘤的发生和发展中起作用。在我们科室,对所有骨髓瘤病例均采用荧光原位杂交(FISH)分析CCND1、FGFR3、MAF和del(17p13)。所有基因异常病例均未通过G显带识别。因此,在评估骨髓瘤的基因异常方面,FISH比G显带更有效。